Related Experiment Video
Updated: Dec 24, 2025

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
Published on: September 22, 2023
[Features of gut microbiota in patients with idiopathic Parkinson's disease]
1Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Abstract:
Objectives: To investigate whether the fecal microbiome of Parkinson's disease patients differs from that of healthy population and explore the pathogenesis and new treatment of idiopathic Parkinson's disease. Methods: A total of 30 patients diagnosed as idiopathic Parkinson disease (PD group) in Beijing Friendship Hospital between April 2017 and June 2018 were enrolled and 30 healthy controls (NC group) were recruited at the same time.Medical records and score of unified Parkinson's disease rating scale (UPDRS) were collected and fresh fecal samples were obtained and stored in refrigerator (-80℃). The microbial compositions of fecal samples were investigated by 16S rRNA gene sequencing targeting the V3-V4 region. The taxa abundance and microbial composition were tested. Results: There was no difference of age and sex in PD and NC groups. Chao1 and Shannon indexes tended to be higher in PD group, yet failed to reach statistic significance (P=0.115 and 0.052). Relative abundance of gut microbiota differed in each taxonomic category. The relative abundance of Firmicutes in PD group was 53.6%(41.7%-64.8%), while that of Bacteroidetes in NC group was 51.7%(31.7%-65.3%). The ratios of Firmicutes to Bacteroidetes were significantly different between the two groups (1.6(0.9-3.4) vs 0.7(0.5-1.4), P=0.001). In Clostridia, Bacilli and Erysipelotrichia of Firmicutes, the relative abundances of Clostridiales, Christensenellaceae, Peptoclostridium, Lactobacillus and Erysipelatoclostridium were higher in PD group (P=0.024, 0.046, 0.036, 0.022 and 0.037). The relative abundance of Prevotella of Bacteroidales, was lower in PD group, yet failed to reach statistic significance (P=0.121). The relative abundances of Alistipes of Rikenellaceae and Butyricimonas of Marinilabiliales in PD group were significantly higher than those in NC group (P=0.047 and 0.033). The relative abundance of Bifidobacterium of Actinobacteria was significanly higher in PD group when compared with NC group (P=0.009). Despite the relatively low abundance, Akkermansia of Verrucomicrobia was significantly higher in PD group than in NC group (P=0.025). Conclusion: The structures of the fecal microbiota differ significantly between PD patients and healthy controls.
Insights
Parkinson's disease patients exhibit distinct fecal microbiome compositions compared to healthy individuals. This study highlights significant differences in gut bacteria ratios and specific taxa, offering potential insights into Parkinson's disease pathogenesis and treatment.
Area of Science:
- Microbiology
- Neuroscience
- Gastroenterology
Background:
- Idiopathic Parkinson's disease (PD) pathogenesis remains incompletely understood.
- The gut microbiome is increasingly recognized for its role in neurological disorders.
Purpose of the Study:
- To investigate differences in fecal microbiome composition between PD patients and healthy controls.
- To explore potential links between gut microbiota alterations and PD pathogenesis.
Main Methods:
- 16S rRNA gene sequencing of fecal samples from 30 PD patients and 30 healthy controls.
- Analysis of microbial taxa abundance and community structure.
- Comparison of Firmicutes to Bacteroidetes ratios and specific bacterial genera.
Main Results:
- Significant differences in the Firmicutes/Bacteroidetes ratio between PD patients and controls (P=0.001).
- Elevated relative abundance of specific bacteria including Clostridiales, Christensenellaceae, Peptoclostridium, Lactobacillus, Erysipelatoclostridium, Alistipes, Butyricimonas, Bifidobacterium, and Akkermansia in PD patients.
- No significant differences in overall alpha diversity (Chao1, Shannon indexes) between groups.
Conclusions:
- The fecal microbiota structure is significantly altered in idiopathic Parkinson's disease patients compared to healthy controls.
- Specific bacterial taxa alterations may contribute to PD pathogenesis.
- These findings suggest the gut microbiome as a potential therapeutic target for Parkinson's disease.
More Related Videos
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.